Found: 7
Select item for more details and to access through your institution.
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 4, p. 1, doi. 10.1038/s41419-019-1387-6
- By:
- Publication type:
- Article
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Physician Utilization Patterns for VEGF-Inhibitor Drugs in the 2012 United States Medicare Population: Bevacizumab, Ranibizumab, and Aflibercept.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.
- Published in:
- Journal of Neuroscience, 2019, v. 39, n. 11, p. 1982, doi. 10.1523/JNEUROSCI.1589-18.2018
- By:
- Publication type:
- Article
Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/6107456
- By:
- Publication type:
- Article
LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3505, doi. 10.3390/cancers12123505
- By:
- Publication type:
- Article
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 8, p. 1421, doi. 10.1093/neuonc/noae059
- By:
- Publication type:
- Article